IL36 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

43 results for “IL36”

Trials

View all 27 →

Not yet recruiting

IL35 Level in Vitiligo

84 participants · First posted Aug 8, 2023

Not yet recruiting

IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP

90 participants · First posted Jul 23, 2020

Interleukin-6 Antagonists in Critically-ill Covid-19 Patients

30 participants · First posted Feb 1, 2022

Drugs

View all 11 →

I036

IL6-110

News

Innovent Initiates First-in-Human Trial of IBI3011, Novel Anti-IL-1RAP Monoclonal Antibody for Gout Treatment

Secukinumab Shows Superior Efficacy Over Ustekinumab in Clearing Skin for Generalized Pustular Psoriasis

Vanda Pharmaceuticals Submits BLA for Imsidolimab to Treat Rare Generalized Pustular Psoriasis

Page 1 of 5